BPA
HOOK

Beacon Pointe Advisors’s HOOKIPA Pharma HOOK Stock Holding History

Beacon Pointe Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,340
Closed -$16.7K – 1326
2024
Q1 		$16.7K Hold
2,340
– – ﹤0.01% 1348
2023
Q4 		$19K Sell
2,340
-160
-6% -$881 ﹤0.01% 1309
2023
Q3 		$15.4K Buy
+2,500
New +$18.4K ﹤0.01% 1325

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Beacon Pointe Advisors's HOOK Position: Q2 2024 in Review

Beacon Pointe Advisors sold out of HOOKIPA Pharma (HOOK) in Q2 2024, closing a stake of 2,340 shares — an estimated $16.7K sold.

Beacon Pointe Advisors first reported a position in HOOK in Q3 2023 and held it in 3 quarters. The position peaked at $19K in Q4 2023. 40 funds tracked by Wall St. Rank hold HOOK as of Q2 2024.

  • Beacon Pointe Advisors reported no remaining HOOKIPA Pharma position as of Q2 2024 after selling out during the quarter.
  • Beacon Pointe Advisors sold 2,340 HOOKIPA Pharma shares in Q2 2024, an estimated $16.7K.
  • Beacon Pointe Advisors first reported a position in HOOKIPA Pharma in Q3 2023 and held it in 3 quarters.
  • Beacon Pointe Advisors's HOOKIPA Pharma position peaked at $19K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2024.

Based on Beacon Pointe Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.